Eiko LifeSciences Balance Sheet Health
Financial Health criteria checks 6/6
Eiko LifeSciences has a total shareholder equity of ₹371.1M and total debt of ₹8.7M, which brings its debt-to-equity ratio to 2.4%. Its total assets and total liabilities are ₹399.0M and ₹27.9M respectively. Eiko LifeSciences's EBIT is ₹10.0M making its interest coverage ratio 6.5. It has cash and short-term investments of ₹49.5M.
Key information
2.4%
Debt to equity ratio
₹8.74m
Debt
Interest coverage ratio | 6.5x |
Cash | ₹49.50m |
Equity | ₹371.08m |
Total liabilities | ₹27.89m |
Total assets | ₹398.97m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 540204's short term assets (₹204.4M) exceed its short term liabilities (₹23.0M).
Long Term Liabilities: 540204's short term assets (₹204.4M) exceed its long term liabilities (₹4.9M).
Debt to Equity History and Analysis
Debt Level: 540204 has more cash than its total debt.
Reducing Debt: 540204's debt to equity ratio has reduced from 29.1% to 2.4% over the past 5 years.
Debt Coverage: 540204's debt is well covered by operating cash flow (483.3%).
Interest Coverage: 540204's interest payments on its debt are well covered by EBIT (6.5x coverage).